Zobrazeno 1 - 10
of 86
pro vyhledávání: '"J. Herth"'
Autor:
Bilal Alashkar Alhamwe, Kadriya Yuskaeva, Friederike Wulf, Frederik Trinkmann, Mark Kriegsmann, Michael Thomas, Corinna Ulrike Keber, Elke Pogge von Strandmann, Felix J. Herth, Saeed Kolahian, Harald Renz, Thomas Muley
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 17, p 9552 (2024)
Immune activation status determines non-small cell lung cancer (NSCLC) prognosis, with reported positive/negative associations for T helper type 2 (TH2) responses, including allergen-specific IgE and eosinophils. Our study seeks to explore the potent
Externí odkaz:
https://doaj.org/article/4bc525fda2934153a29c3a021afb262a
Autor:
Miriam Blasi, Martin E. Eichhorn, Petros Christopoulos, Hauke Winter, Claus Peter Heußel, Felix J. Herth, Rami El Shafie, Katharina Kriegsmann, Mark Kriegsmann, Albrecht Stenzinger, Helge Bischoff, Michael Thomas, Jonas Kuon
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Data are currently insufficient to support the use of adjuvant chemotherapy (ACT) after surgical resection for stage II or III non-small cell lung cancer (NSCLC) in patients aged ≥ 75 years. In this study we evaluated efficacy a
Externí odkaz:
https://doaj.org/article/1b53ff915d164d97a52c735bb73255f9
Autor:
Katharina Buschulte, Philipp Höger, Claudia Ganter, Marlies Wijsenbeek, Nicolas Kahn, Katharina Kriegsmann, Finn Moritz Wilkens, Markus Polke, Sarah El-Hadi, Christoph Lederer, Felix J. Herth, Michael Kreuter
Publikováno v:
Respiration, 102(5), 361-369. Karger
Background: Sarcoidosis is a multisystemic disease with a heterogenous course of disease. Comprehensive information about the complexity and treatment indications is essential for improving patient knowledge and adhering to therapy. Objectives: The a
Autor:
Stephanie J. Yaung, Corinna Woestmann, Christine Ju, Xiaoju Max Ma, Sandeep Gattam, Yiyong Zhou, Liu Xi, Subrata Pal, Aarthi Balasubramanyam, Nalin Tikoo, Claus Peter Heussel, Michael Thomas, Mark Kriegsmann, Michael Meister, Marc A. Schneider, Felix J. Herth, Birgit Wehnl, Maximilian Diehn, Ash A. Alizadeh, John F. Palma, Thomas Muley
Publikováno v:
Cancers, Vol 14, Iss 10, p 2479 (2022)
Monitoring treatment efficacy early during therapy could enable a change in treatment to improve patient outcomes. We report an early assessment of response to treatment in advanced NSCLC using a plasma-only strategy to measure changes in ctDNA level
Externí odkaz:
https://doaj.org/article/68d024aeb9ae41fd80fa7cf0528dd91a
Autor:
Daniel P. Steinfort, Phillip Antippa, Kanishka Rangamuwa, Louis B. Irving, Michael Christie, Ewan Chan, Brett Marinelli, Jie Wang, Ken Y. Yoneda, Shashank Raina, Felix J. Herth
Publikováno v:
Respiration. 102:211-219
Background: Radiofrequency ablation (RFA) is an established modality for percutaneous ablation of non-small cell lung cancer (NSCLC) in medically inoperable patients but is underutilized clinically due to side effects. We have developed a novel, comp
Autor:
Nikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, Daniel Kazdal, Martina Kirchner, Felix J. Herth, Claus-Peter Heussel, Florian Eichhorn, Michael Meister, Thomas Muley, Rami A. Elshafie, Jürgen R. Fischer, Martin Faehling, Mark Kriegsmann, Peter Schirmacher, Helge Bischoff, Albrecht Stenzinger, Michael Thomas, Petros Christopoulos
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Epidermal growth factor receptor-mutated (EGFR + ) non-small-cell lung cancer (NSCLC) patients failing tyrosine kinase inhibitors (TKI) can benefit from next-line targeted therapies, but implementation is challenging. Methods: EGFR + NSCL
Externí odkaz:
https://doaj.org/article/cc0d2140121c4e9798dd4c51c532b090
Autor:
Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Kriegsmann, Claus-Peter Heußel, Felix J. Herth, Hauke Winter, Michael Meister, Thomas Muley, Stefan Fröhling, Solange Peters, Barbara Seliger, Peter Schirmacher, Michael Thomas, Petros Christopoulos, Albrecht Stenzinger
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Immune checkpoint blockade (ICB) expands the therapeutic options for metastatic lung cancer nowadays representing a standard frontline strategy as monotherapy or combination therapy, as well as an option in oncogene-addicted NSCLC after exhaustion of
Externí odkaz:
https://doaj.org/article/8161f49b2e7d4570b7ef75ffd9167dba
Publikováno v:
Respiration. 102:324-326
Autor:
A. Tamashiro, D. Stone, L. Anspach, B. Champine, M. Firpo, P. Maggi, S. Uchiyama, P. Witter, P. Yap-Chiongco, S. Mitchell, C. Percher, D. Heinrichs, J. Goda, T. Grove, T. Cutler, N. Thompson, R. Weldon, L. Overbay, T. Omoto, M. Gadd, E. Hillmer, L. Sharisky, D. Ward, J. Kilbane, D. Roberts, R. Abbott, J. Epps, D. Vogt, H. Healy, S. Murphy, R. Ludwigsen, K. Veinot, K. Mcmahon, A. Detweiler, A. Romanyukha, D. Boozer, K. Consani, P. Angus, N. Vessey, K. Chapman, G. McCabe, E. Cornick, F. Trompier, Y. Ristic, J. Herth, S. Pignet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3489bbbaaabc0549fb05b28674a518ec
https://doi.org/10.2172/1964010
https://doi.org/10.2172/1964010
Autor:
Huriye Seker-Cin, Timothy Tay Kwang Yong, Daniel Kazdal, Klaus Kluck, Markus Ball, Olaf Neumann, Hauke Winter, Felix J. Herth, Claus-Peter Heußel, Rajkumar Savai, Peter Schirmacher, Michael Thomas, Jan Budczies, Michael Allgäuer, Petros Christopoulos, Albrecht Stenzinger, Anna-Lena Volckmar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::602ff8e4d892335ccd308c27f84377c3
https://doi.org/10.2139/ssrn.4454310
https://doi.org/10.2139/ssrn.4454310